Ferulic acid suppresses the inflammation and apoptosis in Kawasaki disease through activating the AMPK/mTOR/NF-κB pathway
In conclusion, FA has potential protective effects on KD, suggesting its promising role as an adjuvant for KD therapy in the future.
Authors
- Huilan Wu
- Xiaoling Guo (ORCID: https://orcid.org/0000-0003-3153-6249)
- Yongmiao Peng
- Weiping Ji
- Yuting Guan (ORCID: https://orcid.org/0000-0003-1866-270X)
- Xing Feng (ORCID: https://orcid.org/0000-0001-8226-3389)
- Yalan Jiang (ORCID: https://orcid.org/0000-0002-6472-0838)
- Ke Sheng (ORCID: https://orcid.org/0000-0002-6696-5409)
- Yijia Wang (ORCID: https://orcid.org/0009-0008-6881-4146)
- Songwei Qian (ORCID: https://orcid.org/0009-0007-8201-1019)
- Haitao Xi (ORCID: https://orcid.org/0000-0002-3673-7042)
- Yuqing Ran
- Pingping Tan
Institutions
- Wenzhou Medical University (CN)
- Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University (CN)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2024-08-29
- DOI
- https://doi.org/10.3389/fphar.2024.1420602
- Citations
- 10
- Primary Topic
- Kawasaki Disease and Coronary Complications
- Type
- article
- Field-Weighted Citation Impact
- 5.73
Funders
- Wenzhou Medical University
- Natural Science Foundation of Zhejiang Province